This model is supported by the detection of TET2 and DNMT3A mutations in tumor-free peripheral blood cells, bone marrow cells, and hematopoietic progenitors, whereas RHOA and IDH mutations are specific to malignant cells from AITL tumors (13). Here, DNMT3A is linked to angioimmunoblastic T-cell lymphoma.